Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 1 OF 3 | DISPLAYING 1 - 15 OF 45 RESULTS

    Lee J.Y. et al., Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract, 10.1016/j.tranon.2017.10.008, Trans. Oncol., Nov 21, 2017

    Song X-H. et al., Euchromatic variants of 8q21.2 in twins, 56(2), 227-229., Twainese Journal of Obstetrics and Gynecology, Apr 01, 2017

    Marshall A.D. et al., CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic, [Epub ahead of print]., Oncogene, Mar 20, 2017

    Lee J.Y. et al., An investigation of the role of gene copy number variations in sorafenib sensitivity in metastatic hepatocellular carcinoma patients, [Epub ahead of print]., J. Cancer, Feb 24, 2017

    Walker L.C. et al., Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers
    , [Epub ahead of print]., Eur. J. Hum. Genetics., Feb 01, 2017

    Lalonde E. et al., Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors, [Epub ahead of print]., Eur. Urology, Nov 01, 2016

    Suzuki Y. et al., Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer, [Epub ahead of print]., Molecular Oncology, Oct 20, 2016

    McIntyre J. et al., Molecular alterations in indolent, aggressive and recurrent ovarian low-grade serous carcinoma, [Epub ahead of print]., Histopathology, Aug 30, 2016

    Apicella M. et al., Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort., [Epub ahead of print]., Oncogene, Aug 15, 2016

    Barber J.C.K. et al., Copy number variation of the REXO1L1 gene cluster; euchromatic deletion variant or susceptibility factor?, [Epub ahead of print]., Eur. J. Hum. Genetics., Aug 03, 2016

    Yoo K-H. et al., Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing., 9(3): 173–178., Trans. Oncol., Jun 01, 2016

    Kim S-T. et al., Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era., [Epub ahead of print]., J, Cancer, May 25, 2016

    Ahn S. et al., A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer., [Epub ahead of print]., Mol Diagn. Ther., May 14, 2016

    Norton N. et al., Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors., [Epub ahead of print]., PLoS ONE, Apr 14, 2016

    Tan I.B. et al., High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer, [Epub ahead of print]., Genome Biology, Feb 12, 2016